How do you validate a new biomarker before clinical use?

My lab is working on a candidate biomarker, and reviewers keep asking for different kinds of validation evidence.

I'm finding it hard to judge what is actually sufficient before moving toward clinical studies.

What validation steps do you consider essential, and which ones are often overkill?